MedTrace Logo

The Effectiveness of Remote Fall Prevention Program vs. Face-to-Face

NCT05018455 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 81

Last updated 2023-11-13

No results posted yet for this study

Summary

Falls are a serious problem in the elderly leading to injuries, morbidity, and consequently a heavy impact on the individual suffering, and society at large.

This study aims to investigate the effectiveness of a remote fall prevention program in comparison with a similar face-to-face program. This study design is a randomized control trial (RCT) with a cross-over in group allocation. The population will include 106 home-dwelling elderly, aged 65 years or more, with low to moderate risk of fall. Participants will be randomized to start intervention in the remote or face-to-face group. Training will be twice weekly for 3 months, after which there will be two weeks of washout, followed by a cross-over between groups. Outcome measures will include fall rate over a year (primary measure), balance, functional testing, subjective measures of fear of falls, quality of life, satisfaction from intervention, adherence, and compliance.

Conditions

  • Fall

Interventions

OTHER

Fall prevention program training based on Otago principles

balance and strength exercises

Sponsors & Collaborators

  • Western Galilee Hospital-Nahariya

    collaborator OTHER_GOV

  • University of Haifa

    lead OTHER

Principal Investigators

  • Hilla Sarig Bahat, PT PhD · Department of Physical Therapy, University of Haifa

Study Design

Allocation
RANDOMIZED
Purpose
PREVENTION
Masking
SINGLE
Model
CROSSOVER

Eligibility

Min Age
65 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2021-11-28
Primary Completion
2023-03-26
Completion
2023-03-26

Countries

  • Israel

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05018455 on ClinicalTrials.gov